Podcasts about services administration hrsa

Mid-August to mid-September marks the time every year when hospitals need to recertify for 340B. Failure to recertify in time could cost a hospital its ability to participate in 340B. 340B Health Associate Director of Policy and Compliance Rebecca Swartz joins us to walk listeners through the process.Why recertification is “exceptionally important”Swartz says annual recertification is not just important, it's also one of the central tenets of 340B compliance. All hospital types except critical access hospitals need to make sure they're meeting the minimum disproportionate share percentage threshold. Hospitals also need to affirm that they are nonprofit facilities and that all their registered parent and child sites continue to have reimbursable outpatient costs and charges on their Medicare cost reports.The cost of losing eligibility is highFailure to recertify 340B eligibility in a timely manner can lock hospitals out of their access to 340B pricing for a year or more. That could deprive a hospital of crucial resources to provide the care and support its patients need.Tips for a smooth recertificationSwartz says a key to making the process go smoothly is to start early and make sure hospital officials have the necessary worksheets and other documentation before the recertification process begins. Authorized officials (AOs) and primary contacts (PCs) should be on the lookout for returned tasks from the Health Resources & Services Administration (HRSA) and other messages to ensure their recertification process is complete. Taking screenshots of each step of the process also can help identify and fix discrepancies that might arise.ResourcesHospital Recertification Begins Aug. 10, Prepare Now!340B Health Registration and Recertification Resource Page340B Health Webinars

With scores of pending lawsuits involving drugmaker and covered entity challenges of how federal and state governments regulate 340B, the courts have become an important arena in the national 340B debate. 340B Health's Vice President of Legal and Policy Amanda Nagrotsky unpacks some of the cases and what they might mean for 340B's future.Courts Wrestle With Issues of Federal and State AuthorityDrug companies have filed about 80 lawsuits challenging state contract pharmacy protection laws. Nagrotsky says drugmakers are arguing these state laws conflict with federal oversight, but most courts so far have ruled that contract pharmacy protection laws fall within a state's ability to regulate drug distribution and delivery. A recent decision from a federal judge in Mississippi was a major win for covered entities because it completely dismissed a drugmaker's challenge to the state's law rather than just ruling on whether to pause enforcement of the law. AbbVie Challenges 340B Patient DefinitionDrugmaker AbbVie is suing the Health Resources & Services Administration (HRSA) directly, arguing that the definition of whom the agency considers a 340B-eligible patient is too broad. AbbVie's own, narrower patient definition would require drug companies to discount far fewer drugs and thus would limit hospital access to 340B savings significantly. The government is asking the court to dismiss the lawsuit on procedural grounds, and 340B Health along with two member hospitals are asking the court to allow them to intervene as defendants and provide additional arguments for why it should throw out the case.Uncertainty Remains Despite GPO, Child Site RulingsFederal district court decisions found that HRSA failed to explain why it adopted a 2013 policy barring certain 340B hospitals' use of group purchasing organizations (GPOs) to make initial purchases for their virtual inventory systems and a 1994 policy establishing registration prerequisites for new 340B hospital outpatient facilities. Although the government opted against appealing the ruling striking down the GPO policy, the underlying prohibition remains in effect, leaving hospitals in limbo as to how HRSA will interpret the law. The government has appealed the child site ruling, and a final decision on that case will have a major impact on how quickly hospitals can use 340B drugs at new child sites.

340B Insight wants to make our podcast the best it can be. To help us succeed, we'd like to hear your thoughts. Please take just a few minutes to complete our listener survey, and we will enter you in a drawing to win a $100 gift card! To participate, please go to 340bpodcast.org/survey.January was set to be the first month of a new 340B rebate pilot program, marking a seismic shift in how the drug discount program functions. But a flurry of court activity just before and after the new year put a sudden pause on the rebate program and left the future of the rebate pilot in question. Amanda Nagrotsky, vice president of legal and policy with 340B Health, joins the show to fill us in on the latest.HRSA Pauses Rebate Implementation After Court RulingIn late December, a federal court in Maine issued a ruling that temporarily blocks the Health Resources & Services Administration (HRSA) from moving forward with the 340B rebate pilot. HRSA then announced it was pausing the pilot and instructed drug companies to continue providing 340B pricing through the traditional upfront discount model. Nagrotsky says the judge found that hospitals had demonstrated a high likelihood of irreversible harm if rebates went forward.Government Appeals, Then ReconsidersImmediately after the ruling, HRSA unsuccessfully argued to the Maine court and an appeals court that the agency still should be able to implement the 340B rebate pilot program while it appealed the initial ruling. After the courts denied that request, the government agreed to voluntarily dismiss its appeal and said it would reconsider its rebate program approvals. Nagrotsky stresses that it is unclear what this means. It could mean the government might overhaul or scrap the rebate program, or it might issue revised approval notices to better explain the rebates' purpose and address concerns of potential harm to 340B hospitals.Medicare Maximum Fair Price Provisions Still Take EffectDespite the legal questions surrounding the 340B rebate pilot program, new Medicare maximum fair price (MFP) provisions did take effect at the beginning of January for the drugs that would have been subject to the rebates. Nagrotsky says that while 340B still can be used for these drugs, covered entities are not entitled to MFP refunds from drug companies in those scenarios. She recommends hospitals closely track expected MFP rebates to identify any missing refunds for claims that did not use 340B drugs.ResourcesDismissal of Appeal Sets Stage for HRSA Reconsideration of 340B Rebates

In this episode, we break down the Data Systems and Website Support Services (DSAWS) BPA opportunity from the U.S. Department of Health and Human Services, supporting Health Resources and Services Administration (HRSA). This single-award BPA, aligned under NAICS 541512, is expected to drive long-term enterprise data, analytics, and digital platform support for nationwide health center oversight.We discuss what the current bridge action signals, why this notice points to a high-value anticipated recompete, and how vendors can begin positioning now—well ahead of the estimated August 2026 RFP release. The conversation highlights critical requirements including enterprise data warehouse operations, advanced data science and analytics, FHIR-based health data collection, secure data sharing, public health websites, dashboards, and compliance reporting systems supporting more than 1,400 health centers and 30+ million patients annually.Listen to the podcast to understand the acquisition strategy early, assess competitive fit, and prepare a proactive capture approach for this mission-critical BPA.Contact ProposalHelper at sales@proposalhelper.com to find similar opportunities and help you build a realistic and winning pipeline.

340B Insight wants to make our podcast the best it can be. To help us succeed, we'd like to hear your thoughts. Please take just a few minutes to complete our listener survey, and we will enter you in a drawing to win a $100 gift card! To participate, please go to 340bpodcast.org/survey.With monumental movement on 340B rebates, changes in Medicare and Medicaid payments, and evolving audit priorities, 2025 has been a transformative year in the world of 340B. We sit down with 340B Health Senior Manager of Policy and Compliance Rebecca Swartz to chronicle some of the biggest developments of such an eventful year and forecast what to expect in 2026.Rebates Take ShapeSwartz says 2025 will go down as the year that a rebate model shifted from a hypothetical approach pushed by drugmakers into a fully developed model with implementation criteria. The Health Resources & Services Administration (HRSA) approved plans for 340B rebate models set to take effect in January for nine of 10 drugs subject to the 2026 Medicare maximum fair prices. Rebates for the remaining drug on that list will kick in April 1. Swartz discusses how hospitals should prepare for this pilot program, which is set to upend decades of established 340B operations and impose intense financial and logistical burdens on safety-net hospitals nationwide.Medicaid, IRA Changes Set To Impact 340B HospitalsThis year also saw massive changes to Medicaid funding as well as Medicare pay changes under the implementation of the Inflation Reduction Act (IRA). Swartz says these developments are projected to shrink safety-net hospital margins even further. Renewed congressional focus is putting 340B in a high-profile spot, with potentially significant implications for the program and hospitals in the coming months.2026 Tips for HospitalsSwartz says she's identified two areas as more of a focus for HRSA audits this year: expanded scrutiny of offsite and on-site trial balances and the ways covered entities list shipping addresses. To prepare for possible shakeups in 2026, she recommends that covered entities begin and maintain cross-functional planning across departments and closely monitor denials, delays, and other costs from new rebate programs in addition to monitoring wholesale acquisition cost (WAC) changes and contract pharmacy developments.Resources340B Health Year-in-Review Webinar: 2025 Highlights and What's on the Horizon

Between new developments on a rebate pilot program, discussions of possible cuts to Medicare payment for 340B drugs, and new action in states nationwide, this fall has been a jam-packed season for 340B. We sit down with 340B Health President and CEO Maureen Testoni to break down the latest.Questions Remain About January's 340B Rebate Pilot After the Health Resources & Services Administration (HRSA) released 340B rebate pilot program guidance over the summer, all nine manufacturers of the 10 drugs subject to Medicare price caps applied to HRSA to implement rebates for the drugs starting in January. Testoni says we expect to find out which plans are approved in early November, as drugmakers need to give eight weeks of notice so covered entities can prepare for the change. Testoni says questions remain about the rebate pilot, but information that the drugmakers' rebate vendor has released so far provides enough detail for hospitals to start preparing for both rebates and price caps.Potential Medicare Cuts Expected To Target 340B HospitalsEarlier this year, the Trump administration released an executive order directing the Centers for Medicare & Medicaid Services (CMS) to survey hospitals on drug acquisition costs with the goal of using the results to set payment rates for Medicare Part B drugs starting in 2027. Testoni says she is concerned the proposed survey will lead to CMS targeting only 340B drugs for cuts that could bring payment rates down to actual acquisition costs, which would be a steeper cut than what the agency imposed during the first Trump administration.States Keep Moving on Contract Pharmacy Protections, 340B MandatesNearly 20 states have contract pharmacy protection laws in place and a small number of drugmakers have sued to block all these statutes. But Testoni says so far, courts have denied those requests and the laws have stayed in effect despite significant opposition advocacy by drugmakers. An increasing number of states also have enacted laws requiring 340B hospitals to report substantial data on their 340B costs and savings, and some are looking to limit how hospitals can use those savings.Resources:Senate Hearing Features Both Bipartisan Support for 340B and Calls for ReformsRead Our Comments on CBO's 340B Growth ReportReview Our 340B Rebate Pilot and IRA ResourcesBeacon Shares New Details on 340B Rebate Pilot Implementation

The organ donation system is under intense scrutiny after the U.S. Department of Health and Human Services directed the Health Resources and Services Administration (HRSA) to investigate America's organ procurement practices. The probe uncovered alarming findings, including nearly 30% of reviewed cases showing serious concerns—ranging from neurological signs inconsistent with organ donation eligibility to a shocking 28 patients who may not have been deceased at the time their organs were harvested.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

A recent report from the U.S. Health Resources and Services Administration (HRSA) reviewed 350 organ transplant cases managed by Kentucky Organ Donor Affiliates, and found one hundred cases had what they called "concerning features." In some cases, donors were still showing neurological signs, indicating the organ procurement process began for patients before they were officially declared deceased. The report led to shocking headlines, a congressional hearing, and many Americans questioning whether they could trust our country's organ donation system. Recently on the FOX News Rundown, the chief of the Health Resources and Services Administration's organ transplant branch, Dr. Raymond Lynch, joined host Jessica Rosenthal to discuss the alarming report, the process of organ transplants, and what they're doing to ensure that they're done properly. Dr. Lynch discussed what went wrong in the cases where the transplant process began too early, but also emphasized how well the system works generally and how it's vital to saving lives. We often have to cut interviews short during the week, but we thought you might like to hear the full interview. Today on Fox News Rundown Extra, we will share our entire interview with Dr. Raymond Lynch, allowing you to learn even more about America's organ donation system. Learn more about your ad choices. Visit podcastchoices.com/adchoices

A recent report from the U.S. Health Resources and Services Administration (HRSA) reviewed 350 organ transplant cases managed by Kentucky Organ Donor Affiliates, and found one hundred cases had what they called "concerning features." In some cases, donors were still showing neurological signs, indicating the organ procurement process began for patients before they were officially declared deceased. The report led to shocking headlines, a congressional hearing, and many Americans questioning whether they could trust our country's organ donation system. Recently on the FOX News Rundown, the chief of the Health Resources and Services Administration's organ transplant branch, Dr. Raymond Lynch, joined host Jessica Rosenthal to discuss the alarming report, the process of organ transplants, and what they're doing to ensure that they're done properly. Dr. Lynch discussed what went wrong in the cases where the transplant process began too early, but also emphasized how well the system works generally and how it's vital to saving lives. We often have to cut interviews short during the week, but we thought you might like to hear the full interview. Today on Fox News Rundown Extra, we will share our entire interview with Dr. Raymond Lynch, allowing you to learn even more about America's organ donation system. Learn more about your ad choices. Visit podcastchoices.com/adchoices

A recent report from the U.S. Health Resources and Services Administration (HRSA) reviewed 350 organ transplant cases managed by Kentucky Organ Donor Affiliates, and found one hundred cases had what they called "concerning features." In some cases, donors were still showing neurological signs, indicating the organ procurement process began for patients before they were officially declared deceased. The report led to shocking headlines, a congressional hearing, and many Americans questioning whether they could trust our country's organ donation system. Recently on the FOX News Rundown, the chief of the Health Resources and Services Administration's organ transplant branch, Dr. Raymond Lynch, joined host Jessica Rosenthal to discuss the alarming report, the process of organ transplants, and what they're doing to ensure that they're done properly. Dr. Lynch discussed what went wrong in the cases where the transplant process began too early, but also emphasized how well the system works generally and how it's vital to saving lives. We often have to cut interviews short during the week, but we thought you might like to hear the full interview. Today on Fox News Rundown Extra, we will share our entire interview with Dr. Raymond Lynch, allowing you to learn even more about America's organ donation system. Learn more about your ad choices. Visit podcastchoices.com/adchoices

After months of litigation in a federal district court, a key decision recently came out in the legal fight over 340B drug rebates. 340B Health Vice President of Legal and Policy Amanda Nagrotsky updates us on the development.Court deals a blow to drugmakersD.C. district court judge Dabney Friedrich ruled on May 15 that manufacturers cannot unilaterally implement rebate models for 340B, agreeing with the Health Resources & Services Administration (HRSA) that the agency effectively has preapproval authority over rebates. In her decision, the judge cited early results from a 340B Health survey finding that shifting 340B to a rebate model would divert significant hospital resources from patient care. Drugmakers have already appealed the ruling.Some bright spots for drugmakers in this decisionAlthough the decision largely went against pharmaceutical companies, the judge ruled that the 340B statute does not categorically prohibit rebates, leaving the door open for government approvals of rebates. The judge also agreed with drugmakers' assertions that HRSA should consider how rebate models could improve 340B compliance and how requiring the sharing of data through rebates could aid in drug company audits of covered entities.Will HRSA stop all rebates from proceeding?Despite this decision, the legal fight over rebates isn't over yet. The judge found that, for three of the manufacturers in these cases, HRSA has yet to issue final decisions with respect to their proposed rebate models. In the case of Sanofi, the judge found that HRSA failed to adequately explain the legal basis for rejecting the drugmaker's rebate model, and she directed the agency to reconsider its decision and explain whether and how it would violate the 340B statute. HRSA sent rebate guidance to the White House for approval earlier this month, though as of recording this episode it was not known what that guidance would say.ResourcesRead Our Analysis of the First Federal Court Decision on Rebates340B Health Continues Court Fight Against Rebates

Health Resources & Services Administration (HRSA) audits of hospitals play a key role in ensuring compliance with 340B rules and regulations. In this episode, Dave Lacknauth, executive director of pharmacy services at Broward Health in Fort. Lauderdale, Fla., joins us to discuss the importance of taking a proactive, comprehensive approach to audit readiness with the goal of ensuring clean audit results. Compliance protects 340B accessBeing prepared for HRSA audits serves a crucial function that ultimately benefits the patients whom hospitals serve, Lacknauth explains. Maintaining the integrity of 340B means protecting access to 340B savings that hospitals can invest in crucial care for community members that need it. Continuous audit readinessLacknauth discusses how Broward Health maintains audit readiness by conducting internal audits, bringing in external consultants, and identifying areas of opportunity for improvement. A robust system of internal reviews means that when HRSA comes knocking, Broward Health is already prepared. This was evident after a recent audit of one of the system's hospitals that resulted in zero recommendations for improvement.Organization, resources, transparency are keyPreparing for audits requires a health system to invest time and resources, but Lacknauth stresses that these investments pay off. Engaging a comprehensive team from various departments in the audit readiness process allows for a health system to have the appropriate level of responsiveness and transparency during a HRSA audit.Resources:Nebraska Is 12th State To Enact Contract Pharmacy ProtectionsIdaho Becomes Fourth State To Mandate 340B Reports From Hospitals

In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Laura Cheever who was, until recently, the Associate Administrator of the HIV/AIDS Bureau at the Health Resources and Services Administration (HRSA). She joined HRSA in 1999 when she served as the national director of the Ryan White AIDS Education and Training Center program. Dr Cheever is Board Certified in Infectious Diseases and continues to provide clinical care for patients with HIV. Dr Cheever describes her early work at HRSA and the Ryan White HIV/AIDS Program. Dr Cheever and Dr Saag then discuss quality measures adopted to demonstrate program effectiveness and the impact these efforts had on funding. They also discuss the staff in the program and their role in working with local providers. They address the role that private insurance, the Affordable Care Act, and different presidential administrations play in the services of the program as well as work left to be done and look ahead to the next ten years of HIV care.0:00 – Introduction1:40 – A discussion of Dr Cheever's early years at the Health Resources and Services Administration (HRSA)7:51 – Implementation of national quality measures for HIV care using data collection through CAREWare11:41 – How did new information impact decision making regarding Ryan White funding decisions15:04 – Impact of changing guidelines on direction given to the Ryan White clinics19:26 – The staff at HRSA and the impact of potential budget cuts on the program24:05 – The role private insurance and the Affordable Care Act had in providing treatment through the Ryan White program 25:10 – Do different presidential administrations influence the services of the Ryan White program27:34 – Discussion of the work left to be done 29:29 – Predictions for the next ten years of HIV care and closing remarks __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Within the past few weeks, drugmaker Johnson & Johnson went head-to-head with 340B hospitals and the federal government over the company's plan to stop paying upfront 340B discounts on two of its top-selling drugs. 340B Health Senior Counsel Amanda Nagrotsky joins us to explain how that conflict played out.HRSA Warns Johnson & Johnson of Strong Punitive ActionsIn letters to J&J, the Health Resources & Services Administration (HRSA) warned the drugmaker that replacing 340B rebates with discounts only would be allowed if approved by the Health and Human Services (HHS) secretary. HRSA gave the company until the end of September to announce that it was going to walk away from its plan or face both civil monetary penalties and the termination of its pharmaceutical pricing agreement (PPA). Nagrotsky said the threat to end the PPA was unprecedented, noting that it would cause the company to lose access to Medicaid and Medicare Part B coverage for all its drugs.Johnson & Johnson Backs Down Under PressureJ&J announced at the end of September that it would walk back its plan to implement rebates in mid-October, bowing to pressure from federal health officials and a bipartisan group of nearly 200 members of Congress who opposed the J&J strategy. The company maintained that it disagreed with HRSA's reasoning and noted that it was reserving all legal rights with respect to rebates. That stance indicates the company is likely to continue its push to implement rebates.The Battle Against Rebates ContinuesDespite the win for hospitals on the J&J rebate scheme, efforts from the drug industry to change the 340B discount structure continue. Drug industry consultant Kalderos is part of ongoing litigation in a federal court in Washington, D.C., over the right to impose rebates. HRSA's references to the concept of HHS approval of rebate proposals also leaves open the door for companies to seek federal consent for such a model.Resources340B Hospitals Prevail on J&J Rebate Plans, But Fight Is Not OverBipartisan U.S House Letter to HHS, Sept. 27 HRSA Letter to Johnson & Johnson, Sept. 27J&J Response to HRSA, Sept. 30

This marks the time of year when 340B hospitals complete the recertification process to maintain their eligibility for 340B. But why is this recertification needed, and what do hospitals need to know before undergoing recertification? Steven Miller, the vice president of pharmacy services for 340B Health, describes what is at stake when it comes to hospitals completing recertification every year. Failure to do so could take a hospital months to correct and cost it millions of dollars – resources that the hospital could be using towards services for patients who need help the most.The key playersMiller says the hospital's authorizing official (AO) and primary contact (PC) are two of the most important figures for recertification. These individuals will be key to verifying and submitting information to the government during the process, and there are important rules governing their roles and responsibilities.Preparing for recertificationMiller says hospitals should have their “ducks in a row” and be ready to undergo recertification as soon as the period begins. This involves having the necessary staff involved, having required documentation on hand, and being prepared to respond quickly to any inquiries from the Health Resources & Services Administration (HRSA).Hospital best practicesMiller has tips for hospitals that want to navigate the recertification process efficiently and accurately. This includes advice on ensuring all the information in the HRSA Office of Pharmacy Affairs Information System is correct, fixing any discrepancies that could lead to future audit findings, and documenting needed changes to make sure they take effect.Resources:340B Health Registration and Recertification Resource340B Health Webinar Archive340B Health Equity Report 2023

In this special episode during Black Maternal Health Week, we delve into some of the critical issues surrounding maternal health disparities in the U.S. and the ongoing initiatives to address them. Host Christie Allen welcomes two distinguished guests: Congresswoman Lauren Underwood, co-chair of the Black Maternal Health Caucus, and Carole Johnson, Administrator of the Health Resources and Services Administration (HRSA). Together, they discuss the groundbreaking Enhancing Maternal Health Initiative, the Momnibus legislation, and the urgent need for comprehensive support for maternal health across the United States. Don't miss this insightful conversation on how we can work together to ensure safer births and healthier outcomes for all families.This show is brought to you by the Alliance for Innovation on Maternal Health (AIM). Join us in the journey toward safer, more equitable maternal care and learn more about AIM at saferbirth.org.This podcast is supported by the Health Resources and Services Administration, HRSA, of the United States Department of Health and Human Services, HHS, as part of an initiative to improve maternal health outcomes. This show is brought to you by the Alliance for Innovation on Maternal Health (AIM). Join us in the journey toward safer, more equitable maternal care and learn more about AIM at saferbirth.org.This podcast is supported by the Health Resources and Services Administration, HRSA, of the United States Department of Health and Human Services, HHS, as part of an initiative to improve maternal health outcomes.

340B hospitals can register certain outpatient locations with the Health Resources & Services Administration (HRSA) as 340B child sites, which allows them to use 340B drugs. HRSA recently announced some changes to how it had been determining this eligibility during the COVID-19 public health emergency. How have these changes affected 340B hospitals, particularly those that had planned new child sites under the previous policy? For the answers to this question and more, we spoke to Chuck Stubbs, a 340B pharmacist with Intermountain Health based in Salt Lake City. How new hospital child sites gain 340B eligibilityChuck explains that 340B child sites are outpatient departments that are not on the main hospital campus but are fully integrated with the hospital parent site. To start using 340B drugs at a new child site, the location must appear on a filed Medicare cost report with associated costs and charges and then be registered with the HRSA Office of Pharmacy Affairs Information System (OPAIS).What changed during the pandemicPrior to the COVID-19 pandemic, the process to start using 340B drugs at a new child site could involve up to nearly two years. Chuck notes that during the pandemic, HRSA indicated that child sites that had not yet been registered could begin using 340B drugs right away if they were for eligible patients. Hospitals believed that shift in policy would be permanent.Where things stand nowThe COVID-era child site eligibility changes did not last. In October 2023, HRSA ended what it called a temporary flexibility, citing the termination of the public health emergency in May 2023. Although HRSA granted a grace period for hospitals to come into compliance, that did not provide protections for planned child sites that had not yet been using 340B drugs. Chuck explains how this affected one of Intermountain's planned sites, and he shares advice for hospitals that are in similar situations.Check out all of our episodes on the 340B Insight podcast website. You also can stay updated on all 340B Health news and information by visiting our homepage. If you have any questions you'd like us to cover in this podcast, email us at podcast@340bhealth.org.Resources:HRSA Announces Policy Restricting Use of 340B at New Child Sites After Transition Period

Dr. Mariel Buqué (pronounced like a bouquet of flowers) is a first-generation Black Dominican psychologist, a world-renowned intergenerational trauma expert, and the author of the bestselling book Break the Cycle: A Guide to Healing Intergenerational Trauma. Her mission is to help reduce the recurrence of Intergenerational ACEs (Adverse Childhood Experiences) within communities of color. Dr. Buqué earned her doctoral degree in counseling psychology at Columbia University, where she also trained as a 3-year fellow in holistic mental health within Columbia University Irving Medical Center (CUIMC), an initiative that was backed by the United States Health Resources and Services Administration (HRSA). There, she offered culturally responsive mental health services across multiple specialty clinics, including Columbia Medical's OB/GYN and Primary Care clinics. In this week's episode, Mariel talks about the intergenerational trauma she has seen as an intergenerational trauma expert. With the help of her book Break the Cycle, she has been able to help people all over the world address the trauma that they have experienced and start healing. Tune in to hear more about her experience as a psychologist and how she has been healing the trauma within her own family as well as within others.  Keep up with Mariel on her website and her LinkedIn. For all Hella Latin@ updates, follow @hellalatinopodcast on Instagram and connect on LinkedIn. More at odalysjasmine.com. To learn more about your ad choices visit megaphone.fm/adchoices Podcast production for this episode was provided by CCST. Learn more about your ad choices. Visit megaphone.fm/adchoices

It is so important to ensure future healthcare leaders have an understanding of rural health, and they can learn a lot in the process. One way to do so is to ensure students have the opportunity to learn about rural healthcare. Our next guest, Dr. Kristin Wilson Clinical Associate Professor and MHA Program Director at the University of Iowa, is excellently ensuring students are well-versed in rural health, no matter what career path they will pursue. In this episode, Kristin shares with us how she integrates rural health into the classroom for future healthcare leaders. We also have a great discussion about the importance of community engagement, and how Kristin is engaging rural communities in the development of MHA curriculum. “I get really excited about the emerging leaders coming into rural healthcare. They are bringing a new energy, a new passion, and they are educated and trained in ways that even I wasn't.” -Dr.Kristin Wilson Kristin Wilson is a clinical associate professor and director of the Master of Health Administration program in the Department of Health Management and Policy. She earned her PhD in public health sciences with a concentration in health management and policy from Saint Louis University College for Public Health and Social Justice, and her Master of Health Administration degree from the same institution.  While at SLU, Dr. Wilson directed the health management and policy MPH and MHA degree programs and served as the executive director of the Heartland Center for Population Health and Community Systems Development.  In addition, since 2018, she has been the principal investigator of the Missouri subcontract to the Midwestern Public Health Training Center for Workforce Development, a multi-state collaborative funded by the Health Resources and Services Administration (HRSA) and located within the University of Iowa College of Public Health. Prior to joining academia, Dr. Wilson held leadership positions within healthcare organizations and has experience at a local, state, national, and international level

It's no longer the relentless killer it was 40 years ago, but HIV is still around and still infecting people. And it remains a focus of the Health and Human Services Department's Health Resources and Services Administration (HRSA). For an update, Federal Drive Host Tom Temin spoke with the Director of the Division of Policy and Data for HRSA's HIV/AIDS Bureau, Michael Kharfen. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

It's no longer the relentless killer it was 40 years ago, but HIV is still around and still infecting people. And it remains a focus of the Health and Human Services Department's Health Resources and Services Administration (HRSA). For an update, Federal Drive Host Tom Temin spoke with the Director of the Division of Policy and Data for HRSA's HIV/AIDS Bureau, Michael Kharfen. Learn more about your ad choices. Visit megaphone.fm/adchoices

The opioid scourge is as much a rural as an urban problem. The Health Resources and Services Administration (HRSA), part of Health and Human Services, has spent five years and hundreds of millions of dollars in grants to rural health services providers to help battle a nearly overwhelming problem. For its work, the HRSA team leading the effort has been named a finalist in the Service to America Medals program. Federal Drive Host Tom Temin spoke with two members in-studio: HRSA's Rural Strategic Initiatives Director, Megan Meacham and Team Lead Sarah O'Donnell. (Deputy director Allison Hutchings is the third member). Learn more about your ad choices. Visit megaphone.fm/adchoices

The opioid scourge is as much a rural as an urban problem. The Health Resources and Services Administration (HRSA), part of Health and Human Services, has spent five years and hundreds of millions of dollars in grants to rural health services providers to help battle a nearly overwhelming problem. For its work, the HRSA team leading the effort has been named a finalist in the Service to America Medals program. Federal Drive Host Tom Temin spoke with two members in-studio: HRSA's Rural Strategic Initiatives Director, Megan Meacham and Team Lead Sarah O'Donnell. (Deputy director Allison Hutchings is the third member). Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

An increase in drug companies restricting 340B discounts and Capitol Hill action on 340B legislation are among several key recent developments that 340B professionals need to be aware of. In this episode, Maureen Testoni, president and CEO of 340B Health, discusses this activity and what it means for the 340B community.Drug Company Restrictions on Contract PharmaciesMaureen shares her concerns about the increasing restrictions, their effects on hospital access to 340B discounts, and expected court decisions regarding manufacturers setting these limits.340B Legislation in Congress and the StatesMaureen provides insights into some critical legislation that affects 340B providers, including federal and state legislation to require data reporting from 340B hospitals.HRSA Policy ChangesThe end of the COVID-19 public health emergency created uncertainty about the Health Resources & Services Administration (HRSA) policy on the use of 340B in new hospital child sites. Maureen explains how hospitals are seeking clarity on the issue and how they should proceed in the meantime. Check out all of our episodes on the 340B Insight podcast website. You also can stay updated on all 340B Health news and information by visiting our homepage. If you have any questions you'd like us to cover in this podcast, email us at podcast@340bhealth.org.

Tell us what you thought of this episode - send us a text!In this episode, Sujani sits down with Dr. Marissa Robinson, coordinator of the Ending the HIV Epidemic initiative at the US Department of Health. They discuss Marissa's education and career, her interest in HIV and the Black community's access to health, and harnessing charisma in your professional life. You'll LearnHow Marissa's personal experiences shaped her interest in the social determinants of health, specifically with HIV and the Black community's access to healthMarissa's experience at Spelman College, a historically Black college for women, and what factors she considered when making choices about educationTips on dealing with rejection, self doubt, and other barriers in your careerHow charisma is essential in leadership and public health and why it is especially important for women of colour to develop this skillToday's GuestDr. Marissa Robinson is a strategic-leader, visionary, and disruptor within the field of Infectious Disease. She focuses on HIV/AIDS research, educating the need to increase opportunities and diversity amongst the public health workforce. She currently leads as the Ending the HIV Epidemic in the U.S. (EHE) initiative Coordinator at the US Department of Health and Human Services (HHS) Office of the Assistant Secretary for Health within the Office of Infectious Disease and HIV/AIDS Policy.Dr. Robinson is a DMV native and is trained in infectious disease epidemiology. She has conducted extensive HIV/AIDS research for over a decade. She began her federal career when she joined the United States Peace Corps as a Community Health and Malaria Prevention volunteer in Togo, West Africa. After returning to the US, Dr. Robinson worked at the Health Resources and Services Administration (HRSA) in the HIV/AIDS Bureau (HAB) on global infectious disease surveillance supporting the President's Emergency Plan for AIDS Relief (PEPFAR) initiative. Following her time at HRSA, Dr. Robinson joined the Centers for Disease Control and Prevention (CDC) where she conducted and maintained data analytics for a Nursing and Midwifery initiative on behalf of PEPFAR for 13 African countries. After her time at CDC, Dr. Robinson joined the CDC Foundation on the Teens Linked to Care pilot program with the CDC's Division of Adolescent and School Health which focused on substance use and sexual risk among youth in rural populations.Dr. Robinson completed her Doctor of Public Health degree as a Goldseeker Scholar at Morgan State University's School of Community Health and Policy. Her dissertation was entitled “A Qualitative Exploration of Preexposure Prophylaxis Among Black Women Attending a Historically Black College and University in the Northeastern United States”. Dr. Robinson completed her doctoral fellowship training at Johns Hopkins School of Medicine Pre-Doctoral Clinical Research Training Program. Dr. Robinson received her Master of Public Health with a concentration in global health, infectious diseases, and a certificate in socio-contextual determinants of health from Emory University's Rollins School of Public Health and her Bachelor of Arts in psychology and public health from Spelman College.ResourcesFollow Marissa on Support the showJoin The Public Health Career Club: A global membership community where public health professionals connect, learn, and support each other in building meaningful and impactful careers. Go from feeling confused, alone and overwhelmed, to feeling confident and in control of your life and career!

In this episode, Sujani sits down with Dr. Marissa Robinson, coordinator of the Ending the HIV Epidemic initiative at the US Department of Health. They discuss Marissa's education and career, her interest in HIV and the Black community's access to health, and harnessing charisma in your professional life. You'll LearnHow Marissa's personal experiences shaped her interest in the social determinants of health, specifically with HIV and the Black community's access to healthMarissa's experience at Spelman College, a historically Black college for women, and what factors she considered when making choices about educationTips on dealing with rejection, self doubt, and other barriers in your careerHow charisma is essential in leadership and public health and why it is especially important for women of colour to develop this skillToday's GuestDr. Marissa Robinson is a strategic-leader, visionary, and disruptor within the field of Infectious Disease. She focuses on HIV/AIDS research, educating the need to increase opportunities and diversity amongst the public health workforce. She currently leads as the Ending the HIV Epidemic in the U.S. (EHE) initiative Coordinator at the US Department of Health and Human Services (HHS) Office of the Assistant Secretary for Health within the Office of Infectious Disease and HIV/AIDS Policy.Dr. Robinson is a DMV native and is trained in infectious disease epidemiology. She has conducted extensive HIV/AIDS research for over a decade. She began her federal career when she joined the United States Peace Corps as a Community Health and Malaria Prevention volunteer in Togo, West Africa. After returning to the US, Dr. Robinson worked at the Health Resources and Services Administration (HRSA) in the HIV/AIDS Bureau (HAB) on global infectious disease surveillance supporting the President's Emergency Plan for AIDS Relief (PEPFAR) initiative. Following her time at HRSA, Dr. Robinson joined the Centers for Disease Control and Prevention (CDC) where she conducted and maintained data analytics for a Nursing and Midwifery initiative on behalf of PEPFAR for 13 African countries. After her time at CDC, Dr. Robinson joined the CDC Foundation on the Teens Linked to Care pilot program with the CDC's Division of Adolescent and School Health which focused on substance use and sexual risk among youth in rural populations.Dr. Robinson completed her Doctor of Public Health degree as a Goldseeker Scholar at Morgan State University's School of Community Health and Policy. Her dissertation was entitled “A Qualitative Exploration of Preexposure Prophylaxis Among Black Women Attending a Historically Black College and University in the Northeastern United States”. Dr. Robinson completed her doctoral fellowship training at Johns Hopkins School of Medicine Pre-Doctoral Clinical Research Training Program. Dr. Robinson received her Master of Public Health with a concentration in global health, infectious diseases, and a certificate in socio-contextual determinants of health from Emory University's Rollins School of Public Health and her Bachelor of Arts in psychology and public health from Spelman College.ResourcesFollow Marissa on LinkedIn or Twitter or send her an email Learn more about Spelman College Listen to The "It" FactorSupport the showJoin The Public Health Career Club: the #1 hangout spot and community dedicated to building and growing your dream public health career.

We speak with Dr. Anthony Schalf from the Health Resources and Services Administration (HRSA) about preventative medicine. Preventive Medicine is a medical specialty focused on assessing and promoting the health of populations. Whether it's called public health, community health, or population health, the idea is a focus on the health outcomes within a defined population, not just an individual patient. Join us to learn more about how FQHCs can work with Preventive Medicine trained providers.

What is a Rural Health Clinic? A Rural Health Care Clinic (RHC) is a clinic designed to provide quality care to patients in rural areas. They are Medicare certified programs that must be established in areas designated as rural shortage areas. An RHC is not permitted to care for patients of mental diseases or rehabilitation services. At least fifty percent of the time the clinic is open there must be a nurse practitioner, midwife, or physician assistant to provide care to patients. These medical professionals are under direction of a physician. RHCs are required to staff personnel, but there are no requirements to maintain a Board of Directors. Two types of Rural Health Clinics exist: (1) an Independent Rural Health Clinic which is a freestanding clinic not associated with a hospital or any type of Health Care Agency; and (2) a Provider Based Rural Health Clinic which is the subordinate of a hospital, home health agency or nursing facility. Also, Rural Health Clinics do not receive federal funding for start-up or expansion. What is an FQHC? A Federally Qualified Health Center are primary care outpatient centers that serve underserved communities. FQHCs qualify for reimbursements from the Health Resources and Services Administration (HRSA), Medicaid, and Medicare. An FQHC can receive government grants, donations, and private sectors in addition to the Medicaid reimbursements. To be considered a Federally Qualified Health Center a clinic must meet certain requirements including: (1) serving an underserved area; (2) provide care on a ‘sliding fee scale' which is based on ability to pay; (3) complete required annual reports; (4) provide holistic and social services; (5) and not be approved as a rural health clinic. Web: www.JonesHealthLaw.com Phone: (305)877-5054 Instagram: @JonesHealthLaw Facebook: @JonesHealthLaw Youtube: @JonesHealthLaw --- Support this podcast: https://podcasters.spotify.com/pod/show/joneshealthlaw/support

We just ended the 117th Congress with some wins, some losses, but most importantly, a plan to keep moving forward to improve the Occupational Therapy profession for both patients and practitioners! That's why this week on The Amplify OT Podcast, I am talking about the 2022 OT advocacy wins and losses from congress! Join the Amplify OT Membership today to take control of your career! It's time to become your own best resource on Medicare and advocacy! Congress ended its term with a massive 1.7 Trillion Dollar legislative package- The Omnibus Reconciliation Act of 2023 (otherwise referred to as the Omnibus Bill). Within this bill, there are quite a few healthcare policies that impact our practice. To recap, here are some of the wins and areas for improvement that resulted from the 117th Congress: The Wins: The Allied Health Workforce Diversity Act was officially passed! Another extension was passed to allow Occupational Therapy practitioners and others to continue providing services via Telehealth for Medicare beneficiaries and receive reimbursement until the end of 2024. The Lymphedema Treatment Act was passed to expand the coverage to include Lymphedema garments as well as other commonly prescribed items. A new Medicare mental health benefit was passed for intensive outpatient services that are provided at Federally Qualified Health Centers (FQHC) or rural health clinics. A correction was made to a grant administered by the Health Resources and Services Administration (HRSA) to expand their funding that allows OT programs to apply for behavioral health workforce education training to doctoral-level programs. Areas for Improvement: Congress mitigated the conversion factor in Medicare Part B payments (or the Medicate Physicians Fee Schedule) which, in turn, leads to cuts. Revised supervision and exemptions for rural and medically underserved areas under the S.M.A.R.T. Act were not included in the bill. You might be wondering what's next. AOTA is going to continue analyzing this bill to look for opportunities we can benefit from (& spoiler alert: they have already identified a few) and now it's time to reintroduce the bills that did not pass and look toward introducing new legislation. Thanks for listening! If you found this episode helpful, don't forget to follow, rate and review the show. To learn more about Amplify OT head to https://amplifyot.com/ Need CEUs? Save 40% off on your Medbridge subscription by using code “AmplifyOT” at checkout or by visiting https://www.medbridgeeducation.com/amplify-ot. Medbridge has great CEUs on the OASIS and Medicare Reimbursement. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/amplifyot/message Support this podcast: https://anchor.fm/amplifyot/support

In this episode, we speak to Kathleen Metzker and Sara Reid about centering trauma literacy in the health center medical home and how health systems can cultivate trauma-aware practices as part of their delivery of care. Metzker and Reid are interviewed by Jillian Bird, Director of Training and Technical Assistance at the National Nurse-Led Care Consortium to support providers working at community health centers across the country.  Kathleen Metzker is the Director of Integrative Health and Mind Body Services at the Stephen and Sandra Sheller 11th Street Family Health Services of Drexel University. In this multidisciplinary health care setting, more than 6,000 patients access a range of services, including: primary care, behavioral health, dental services, and health and wellness programs. Sara Reid is a health educator, support group facilitator and consumer board member for the Boston Healthcare for the Homeless. She is a public speaker and delivers trainings on transgender priorities, including teaching medical and behavioral health providers how to provide gender-affirming healthcare. Support for this episode comes from the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS). It is part of an award totaling $550,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.

In this episode, we have a conversation with two community health professionals about the role community health centers play in addressing community violence. Cheryl Seay and Wayne Clark share how they are working to improve access to health care and reduce violence in their communities. Seay and Clark are interviewed by Jillian Bird, Director of Training and Technical Assistance at the National Nurse-Led Care Consortium to support providers working at community health centers across the country. Cheryl Seay is the Program Manager for the Center for Community Health Workers at Penn Medicine at Home and is the founder of the Jarrell Christopher Seay Love and Laughter Foundation, a nonprofit focused on addressing gun violence and community health. Wayne Clark is a Health Navigator at Roots Community Health Center, Inc. He is also the founder and executive director at Oakland Impact Center, which provides innovative counseling, mentoring, skill building, violence prevention training, and more. Support for this episode comes from the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS). It is part of an award totaling $550,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.

Where do doctors go for advice if they need help treating patients with addiction? NCCC is like the National Poison Center but with a focus on drug addiction. NCCC provides free advice from national experts to doctors and clinicians treating patients with addiction. On this podcast hear from the NCCC experts on how doctors give advice to other doctors. NCCC - National Clinician Consultation Center For 30 years, the National Clinician Consultation Center (NCCC) has offered free, on-demand tele-consultation on HIV and viral hepatitis to health care providers across the U.S.  In 2015, with support from the Bureau of Primary Health Care (BPHC) at the Health Resources and Services Administration (HRSA), the NCCC launched a new National Substance Use Warmline (855.300.3595) to address providers' clinical questions regarding substance use disorder prevention, evaluation, and medical management.  The Warmline's multi-disciplinary team of experienced addiction medicine professionals has provided over 3,000 individually tailored consultations across a broad range of topics, such as novel buprenorphine initiation strategies; alcohol withdrawal management for older adults with complex comorbidities; and pharmacotherapy considerations for pregnant and parenting individuals.  The Warmline welcomes calls from any U.S.-affiliated clinician, especially providers working in safety net healthcare systems and rural communities.  More information is available at: nccc.ucsf.edu. Brenda Goldhammer, MPH  - NCCC Program Director Brenda Goldhammer has been working in the HIV/AIDS field for nearly 30 years.  She received her Master's in Public Health from the University of California at Los Angeles where she was awarded the Improving Public Health in Southern California Fellowship for her work with social service providers serving people who are unhoused and the University Fellowship for academic excellence.  Before joining the National Clinician Consultation Center, Ms. Goldhammer launched her career with the University of California, San Francisco (UCSF) at the Center for AIDS Prevention Studies as an HIV/AIDS Intervention Specialist.  As Program Director for the National Clinician Consultation Center based out of UCSF, she provides operational and strategic leadership including overseeing the program's technological and infrastructure improvements.  She also manages the projects collaborative partnerships and public relations. Jesse Ristau, MD - NCCC Physician Consultant Dr. Jesse Ristau completed her M.D. at Boston University Medical Center, Primary Care Internal Medicine residency at UCSF and Primary Care and Addiction Medicine Fellowship at UCSF. Dr. Ristau is now an Assistant Professor on faculty at UCSF Health Division of General Internal Medicine and practices primary care and addiction medicine. She also provides addiction consultation with the UCSF NCCC Substance Use Warmline and clinical care for inpatient and outpatient addiction specialty clinics in San Francisco. Mishka Terplan, MD MPH FACOG DFASAM - NCCC Physician Consultant Dr. Mishka Terplan is board certified in both obstetrics and gynecology and in addiction medicine. His primary clinical, research, public health, and advocacy interests lie along the intersections of reproductive and behavioral health. He is Medical Director at Friends Research Institute and adjunct faculty at the University of California, San Francisco where he is a Substance Use Warmline clinician for the National Clinician Consultation Center. Dr. Terplan has active grant funding and has published over 140 peer-reviewed articles with emphasis on health inequities, discrimination, and a

Join the EMGuidewire team and Drs. Allen and Fox from Carolinas Medical Center as they discuss tips for Mitigating Anxiety and Pain in the Pediatric patient. This episode is published in concert with EMSC Innovation and Improvement Center.  The Emergency Medical Services for Children Innovation and Improvement Center is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award (U07MC37471) totaling $3M with 0 percent financed with nongovernmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.

Kids, pain, and the emergency department can be a set up for disaster.  In this podcast, three pediatric specialists get into why that is and how we can all be better at treating kids in pain. Tag us on social media, @empulsepodcast, or reach out via email empulsepodcast@gmail.com, or connect through our website, ucdavisem.com. Encourage your friends and colleagues to listen and share their perspective, too! ***Please rate us and leave us a review on iTunes! It helps us reach more people.*** Hosts: Dr. Julia Magaña, Associate Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Associate Professor of Emergency Medicine at UC Davis Guests: Kimberly Wheatley, RN, UC Davis Pediatric Nurse Katheryn Finan, UC Davis Child Life Specialist Resources: The Emergency Medical Services for Children Innovation and Improvement Center is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award (U07MC37471) totaling $3M with 0 percent financed with nongovernmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov. Email km@emscimprovement.center Follow on Twitter @EMSCImprovement References: EIIC Pediatric Pain toolkit Goyal MK, Johnson TJ, Chamberlain JM, Cook L, Webb M, Drendel AL, Alessandrini E, Bajaj L, Lorch S, Grundmeier RW, Alpern ER; PEDIATRIC EMERGENCY CARE APPLIED RESEARCH NETWORK (PECARN). Racial and Ethnic Differences in Emergency Department Pain Management of Children With Fractures. Pediatrics. 2020 May;145(5):e20193370. doi: 10.1542/peds.2019-3370. Epub 2020 Apr 20. PMID: 32312910; PMCID: PMC7193974. Johnson TJ, Weaver MD, Borrero S, Davis EM, Myaskovsky L, Zuckerbraun NS, Kraemer KL. Association of race and ethnicity with management of abdominal pain in the emergency department. Pediatrics. 2013 Oct;132(4):e851-8. doi: 10.1542/peds.2012-3127. Epub 2013 Sep 23. PMID: 24062370; PMCID: PMC4074647.

SPECIAL EPISODE! This episode is co-sponsored by Health Partners on IPV + Exploitation, a project of Futures Without Violence that works with community health centers to address and prevent intimate partner violence, human trafficking, and exploitation. Tune in to hear FUTURES' Surabhi Kukke talk with Dr. Dana Hines, a national expert on the intersections of HIV and IPV, about the ways that the HRSA HIV/AIDS Bureau creates opportunities through the Ryan White Program for community health centers and other grantees to address and prevent domestic and sexual violence. What did you think about this episode? Let us know! https://redcap.link/snxltwij Resources: https://ryanwhite.hrsa.gov/about/parts-and-initiatives/part-d-swic www.healthpartnersipve.org https://ipvhealthpartners.org/partner/ Health Partners on IPV + Exploitation, a project of Futures Without Violence is funded by HRSA's Bureau of Primary Health Care to provide free training and technical assistance to health centers on the topics of intimate partner violence, human trafficking and exploitation. A toolkit for health centers IPVHealthPartners.org includes an MOU template for building new partnerships discussed in today's episode. Learn more about our resources and programs and join our newsletter at www.healthpartnersipve.org. This podcast was developed with support from the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $650,000 with 0 percent financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more info visit HRSA.gov.

For paramedics, click here for CAPCE credits.  Brought to you by Urgent Admin which is an intuitive one-touch solution that connects in-field clinicians and medical directors in real-time, Ouch-less Pediatrics Happy EMS Week: Pediatrics Day! The But Why EMS Podcast team would like to highlight NAEMSP's newest podcast to our family  The Pediatric EMS Podcast In their first episode, hosts Dr. Joseph Finney and Dr. Joelle Donofrio-Odmann talk about Safely and effectively managing pain in our pediatric patients. Medical directors and prehospital clinicians must be able to identify gaps in pediatric pain management and provide the necessary QA/QI to close those gaps. In this episode, we focus on exactly that, with several experts in EMS joining us to offer their knowledge and critical appraisal of the evidence in order to identify and close the gaps in the management of pain in children. Click here to check it out today! Thank you for listening! Hawnwan Philip Moy MD  Gina Pellerito EMT-P John Reagan EMT-P Please subscribe and review our podcasts on: Apple Amazon Google Podcast Stitcher   Disclaimer The Emergency Medical Services for Children Innovation and Improvement Center is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award (U07MC37471) totaling $3M with 0 percent financed with nongovernmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.     To learn more about the Emergency Medical Services for Children Innovation and Improvement Center visit https://emscimprovement.center   Email km@emscimprovement.center Follow on Twitter @EMSCImprovement   Sources: International Association for the Society of Pain Subcommittee on Taxonomy  WT Zempsky NL Schechter 2003 What's new in the management of pain in children Pediatrics Rev 24 10 337 347 16  SJ Weisman B Bernstein NL Schechter 1998 Consequences of inadequate analgesia during painful procedures in children Arch Pediatrics Adolescent Med 152 2 147 149 17  JT Pate 1996 Childhood medical experience and temperament as predictors of adult fu Educational Module on Prehospital Pain Management in Children (Targeted Issues Grant): http://www.youtube.com/watch?v=Tn3MF_4-9iQ&feature=youtu.be Lorin R. Browne, Manish I. Shah, Jonathan R. Studnek, Daniel G. Ostermayer, Stacy Reynolds, Clare E. Guse, David C. Brousseau & E. Brooke Lerner (2016) Multicenter Evaluation of Prehospital Opioid Pain Management in Injured Children, Prehospital Emergency Care, 20:6, 759-767, DOI: 10.1080/10903127.2016.1194931

Ouch-less Pediatrics For CAPCE Credit click here! Happy EMS Week: Pediatrics Day! The PEC Podcast team would like to highlight NAEMSP's newest podcast to our family  The Pediatric EMS Podcast In their first episode, hosts Dr. Joseph Finney and Dr. Joelle Donofrio Odmann talk about Safely and effectively managing pain in our pediatric patients. Medical directors and prehospital clinicians must be able to identify gaps in pediatric pain management and provide the necessary QA/QI to close those gaps. In this episode, we focus on exactly that, with several experts in EMS joining us to offer their knowledge and critical appraisal of the evidence in order to identify and close the gaps in the management of pain in children. As always THANK YOU for listening. Hawnwan Philip Moy MD (@pecpodcast) Scott Goldberg MD, MPH (@EMS_Boston) Jeremiah Escajeda MD, MPH (@jerescajeda) Joelle Donofrio-Odmann DO (@PEMems) Maia Dorsett MD PhD (@maiadorsett) Lekshmi Kumar MD, MPH (@gradyMED1) Disclaimer The Emergency Medical Services for Children Innovation and Improvement Center is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award (U07MC37471) totaling $3M with 0 percent financed with nongovernmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov To learn more about the Emergency Medical Services for Children Innovation and Improvement Center visit https://emscimprovement.center Email km@emscimprovement.center Follow on Twitter @EMSCImprovement Sources: International Association for the Society of Pain Subcommittee on Taxonomy  WT Zempsky NL Schechter 2003 What's new in the management of pain in children Pediatrics Rev 24 10 337 347 16  SJ Weisman B Bernstein NL Schechter 1998 Consequences of inadequate analgesia during painful procedures in children Arch Pediatrics Adolescent Med 152 2 147 149 17  JT Pate 1996 Childhood medical experience and temperament as predictors of adult fu Educational Module on Prehospital Pain Management in Children (Targeted Issues Grant): http://www.youtube.com/watch?v=Tn3MF_4-9iQ&feature=youtu.be Lorin R. Browne, Manish I. Shah, Jonathan R. Studnek, Daniel G. Ostermayer, Stacy Reynolds, Clare E. Guse, David C. Brousseau & E. Brooke Lerner (2016) Multicenter Evaluation of Prehospital Opioid Pain Management in Injured Children, Prehospital Emergency Care, 20:6, 759-767, DOI: 10.1080/10903127.2016.1194931

This week, we are joined for the latest in our regular check-ins with 340B Health President and CEO Maureen Testoni. Maureen analyzes the top issues in 340B that occurred in the early months of 2022. These include updates on the 340B community pharmacy dispute and a new law that protects 340B eligibility for hospitals serving on the front lines of the COVID-19 pandemic. Drug Company 340B Restriction Trends There now are 16 companies restricting 340B discounts to safety-net hospitals on drugs dispensed at community pharmacies. Maureen shares updates and in-depth analysis on the three main trends she is seeing in these restrictive 340B policies. How 340B Health and Hospitals are Working to Restore Discounts Maureen summarizes the decisions courts have made on the community pharmacy dispute and what will happen next in the legal process. She explains how 340B Health is responding to all the developments and what 340B hospitals should do to help move this issue toward a resolution.  Protecting 340B Hospitals from Losing EligibilityPresident Biden recently signed into law legislation protecting 340B hospitals from losing eligibility for the program due to the COVID-19 pandemic. Maureen describes the changes in patient demographics some hospitals have seen during the public health emergency, the advocacy efforts that made the law possible, and the details hospitals need to know about the law's implementation.   New HRSA Leadership In the past few months, the Health Resources & Services Administration (HRSA), which oversees the 340B program, had two new leaders join its team. Maureen discusses what this change in leadership means for 340B. Check out all of our episodes on the 340B Insight podcast website. You also can stay updated on all 340B Health news and information by visiting our homepage. If you have any questions you'd like us to cover in this podcast, email us at podcast@340bhealth.org.Resources  Additional Resources on 340B Community Pharmacy Dispute  340B Health Template to Protest Drug Companies Patient Claims Data Demands  HRSA Attestation Form for Reinstatement into the 340B Drug Pricing Program  Upcoming 340B Health Webinars 

A season finale. . . with special guests! Edward Phillips, MD, and Juna Gjata, creators of the podcast Food, We Need to Talk, join us to comment on common themes between the two series, and suggest what should be next in your food & health podcast listening line up. The  first season of Food, We Need to Talk is available online. Two episodes cited specifically in this conversation were: This Is Your Brain on Cheesecake and Disordered Eating and Eating Disorders. We also talked about what makes a "fad" diet and common characteristics of popular diets that don't support sustainable healthy eating strategies, covered in Doomed If You Diet, Doomed If You Don't. The problems with the good food / bad food mindset are explored in Good Food, Bad Food and also What the Heck Should We Eat? In this first season they do not go deep into diets tailored for treating or managing specific health conditions. But what will happen in the next season? We'll have to tune in March 21st to find out. . .  The podcast mentioned when I steal Steven Levitt's interview structure is People I Mostly Admire from Freakonomics Radio, which also has a health care podcast in its portfolio, Freakonomics, MD (Steve interviews the host on this 2021 episode).   You were promised links to microbiome-focused podcast episodes. There are a lot. It is literally a category of podcast unto itself.  A few options that are clear about both the interesting questions before us & the limits of the current science:BBC Good Food Health Podcast - Dr. Megan RossiStuff You Should Know - Your Gut Is Also a BrainWhat Went Wrong at uBiome Part 1 and Part 2 - The Journal (also a cautionary tale in what fraudulent medical billing looks like) Find easy links to this season's episodes in order here. And an extended playlist here. This season of Policy in Plainer English is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $189,892.00 with 0 percentage financed with non governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS or the U.S. Government.This podcast is part of the Food Access in Health Care program at Bi-State Primary Care Association.

Black women have twice the rate of preterm birth compared to white women, and that has persisted despite decades of research, despite differences in socioeconomic status, maternal education, access to prenatal care. When you pair or look at a Black woman and a white woman who are pregnant, the Black woman will have their baby early at twice the rate of white women. Nurse midwife, mindfulness teacher, and adjunct professor Karen Sheffield-Abdullah is trying to figure out why.Today's episode is hosted by Dr. Kristin Tully, co-chair of the MHLIC Innovation Support Core, and researcher at UNC Chapel Hill.Learn more about us, explore our resource center and find support for all maternal health professionals at MaternalHealthLearning.org.Maternal Health Innovation is a product of the Maternal Health Learning and Innovation Center and is produced by Earfluence.Music provided by Graham Makes.This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U7CMC33636 State Maternal Health Innovation Support and Implementation Program Cooperative Agreement. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.

RMOMS is a federally funded grant program that seeks to improve maternal health in rural communities. The Texas and Missouri RMOMS representatives with us today that you'll hear from our awardees of the initial pilot between the federal Office of Rural Health Policy and the Maternal and Child Health Bureau. Today, we discuss innovative solutions these teams are implementing to address issues facing birthing people in rural areas.Today's guests are Anna Taranova, Barb Gleason, Mariluz Martinez, Susan Kendig, Rebecca Burger, and Morgan Nesselrodt.Today's episode is hosted by Tanisa Adimu, assistant project director at the Georgia Health Policy Center and is a co-leader of the Community Health Systems Development team. Learn more about us, explore our resource center and find support for all maternal health professionals at MaternalHealthLearning.org.Maternal Health Innovation is a product of the Maternal Health Learning and Innovation Center and is produced by Earfluence.Music provided by Graham Makes.This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U7CMC33636 State Maternal Health Innovation Support and Implementation Program Cooperative Agreement. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.

For true innovation in maternal health to occur, we need to take a look at what works (and what needs improving) with maternal health in various cultures. On this episode, we discuss learning from tribal and indigenous cultures, and the programs and trainings involved. Today's guests are Heidi Christensen and Lynn Lane, Maternal Health Innovation Program Managers at Arizona Department of Health Services, and Reena Oza-Frank and Ali Stevens with Ohio Department of Health's Division of Maternal, Child, and Family Health.Today's episode is hosted by Kimberly Harper, the Perinatal Neonatal Outreach Coordinator with UNC Maternal and Infant Health.Learn more about us, explore our resource center and find support for all maternal health professionals at MaternalHealthLearning.org.Maternal Health Innovation is a product of the Maternal Health Learning and Innovation Center and is produced by Earfluence.Music provided by Graham Makes.This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U7CMC33636 State Maternal Health Innovation Support and Implementation Program Cooperative Agreement. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.

Vanessa Caldari founded Mujeres Ayudando Madres because she I realized that midwifery care, especially in Puerto Rico, was really for people with access to the finances and the education to have that care. She didn't want midwifery care to be a privilege, so she did something about it.Vanessa Caldari is the founder of Mujeres Ayudando Madres, a nonprofit in Puerto Rico that supports birthing people from gestation to parenthood and helps them make informed birthing decisions.Today's episode is hosted by Leslie deRosset, implementation specialist at the University of North Carolina at Chapel Hill, where she works on maternal health child projects housed at Gillings School of Global Public Health.Learn more about us, explore our resource center and find support for all maternal health professionals at MaternalHealthLearning.org.Maternal Health Innovation is a product of the Maternal Health Learning and Innovation Center and is produced by Earfluence.Music provided by Graham Makes.This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U7CMC33636 State Maternal Health Innovation Support and Implementation Program Cooperative Agreement. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.

In the Appalachian region, poverty is a huge concern. Too often, pregnant women miss appointments because they don't have the money for gas. Or they'll have a baby on Thursday and return to work on Monday because they need the paycheck. And breastfeeding can be seen as for "hillbillies" or "rednecks." For our guests today, they saw the problem and found a way to help - a hotline to address transportation gaps, access to care, and support during the pandemic.Stephanie Hutchinson is the Founder and President of Appalachian Breastfeeding Network (ABN), Kate Tuttle is the membership chair of ABN, and Jeanna Spears is the ABN secretary and librarian.Today's episode is hosted by Andrea Serano, Program Manager at Reaching Our Sisters Everywhere (ROSE).Learn more about us, explore our resource center and find support for all maternal health professionals at MaternalHealthLearning.org.Maternal Health Innovation is a product of the Maternal Health Learning and Innovation Center and is produced by Earfluence.Music provided by Graham Makes.This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U7CMC33636 State Maternal Health Innovation Support and Implementation Program Cooperative Agreement. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.

Black women have twice the rate of preterm birth compared to white women, and that has persisted despite decades of research, despite differences in socioeconomic status, maternal education, access to prenatal care. When you pair or look at a Black woman and a white woman who are pregnant, the Black woman will have their baby early at twice the rate of white women. Nurse midwife, mindfulness teacher, and adjunct professor Karen Sheffield-Abdullah is trying to figure out why.Today's episode is hosted by Dr. Kristin Tully, co-chair of the MHLIC Innovation Support Core, and researcher at UNC Chapel Hill.Learn more about us, explore our resource center and find support for all maternal health professionals at MaternalHealthLearning.org.Maternal Health Innovation is a product of the Maternal Health Learning and Innovation Center and is produced by Earfluence.Music provided by Graham Makes.This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U7CMC33636 State Maternal Health Innovation Support and Implementation Program Cooperative Agreement. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.

Eight years ago, when To-wen Tseng returned to work after giving birth to her first child, her right to pump at work was denied and the company refused to provide either a space or a break time to pump (lawsuit).Stevie Merino (Birthworkers of Color Collective) is a doula and lactation professional whose graduate school research focuses on Pacific Islander and Chamorro breastfeeding, chest feeding, birth traditions, and the disparities in birthing health outcomes.Today they discuss the fight for lactation rights.This episode is hosted by Dr. Kimarie Bugg, President and CEO of Reaching Our Sisters Everywhere Inc (ROSE).Learn more about us, explore our resource center and find support for all maternal health professionals at MaternalHealthLearning.org.Maternal Health Innovation is a product of the Maternal Health Learning and Innovation Center and is produced by Earfluence.Music provided by Graham Makes.This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U7CMC33636 State Maternal Health Innovation Support and Implementation Program Cooperative Agreement. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.

The sad reality is that people in rural communities don't have as many resources to healthcare, and that includes adequate prenatal and maternity care. For Shaunette Howard, her biggest role is advocating for birthing people and their families so that they can get as many of the necessary resources as possible.Today's episode is hosted by Dr. Kristin Tully, co-chair of the MHLIC Innovation Support Core, and researcher at UNC Chapel Hill.Learn more about us, explore our resource center and find support for all maternal health professionals at MaternalHealthLearning.org.Maternal Health Innovation is a product of the Maternal Health Learning and Innovation Center and is produced by Earfluence.Music provided by Graham Makes.This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U7CMC33636 State Maternal Health Innovation Support and Implementation Program Cooperative Agreement. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.

According to today's guest, Dr. Rachel Caskey, "stark disparities exist whereby Black women are nearly three times more likely to die from a pregnancy-related condition compared to white women. In addition, it is estimated that the majority of deaths are actually preventable."  Today, we talk about what can be done to fix these inequities and disparities.Dr. Rachel Caskey is the chief of the division of academic internal medicine and associate professor of internal medicine and pediatrics at University of Illinois - Chicago. She's also the principal investigator at I-PROMOTE Illinois.Today's episode is hosted by Katherine Bryant, Research Associate and Project Manager for the UNC Center for Maternal and Infant Health and a Project Director in the UNC Jordan Institute for Families.Learn more about us, explore our resource center and find support for all maternal health professionals at MaternalHealthLearning.org.Maternal Health Innovation is a product of the Maternal Health Learning and Innovation Center and is produced by Earfluence.Music provided by Graham Makes.This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U7CMC33636 State Maternal Health Innovation Support and Implementation Program Cooperative Agreement. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.

For Birth Sisters Doula Services' LaToshia Rouse, becoming a doula changed her entire life because she gets to give people exactly what she wishes she had while delivering her 4 children (including triplets). According to LaToshia, "the reward is instant. It's addictive and you get to do it again and again, and you keep hearing the stories."  But unfortunaely, there's a dark side to stories, which include hearing about the maternal mortality statistics and mistreatment numbers. For LaToshia, that's just another opportunity to help. Today's episode is hosted by Dr. Kristin Tully, co-chair of the MHLIC Innovation Support Core, and researcher at UNC Chapel Hill. Learn more about us, explore our resource center and find support for all maternal health professionals at MaternalHealthLearning.org.Maternal Health Innovation is a product of the Maternal Health Learning and Innovation Center and is produced by Earfluence.Music provided by Graham Makes.This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U7CMC33636 State Maternal Health Innovation Support and Implementation Program Cooperative Agreement. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.

Join us as we speak with experts about ways we can better serve women and birthing people and advance maternal health equity. From what is going well to what needs to be done to improve our health outcomes, we will share innovative work, new strategies, and impactful stories from people who are changing birthing care for families in our country. Learn more about us, explore our resource center and find support for all maternal health professionals at MaternalHealthLearning.org.Maternal Health Innovation is a product of the Maternal Health Learning and Innovation Center and is produced by Earfluence.Music provided by Graham Makes.This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U7CMC33636 State Maternal Health Innovation Support and Implementation Program Cooperative Agreement. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.